Matches in SemOpenAlex for { <https://semopenalex.org/work/W32481776> ?p ?o ?g. }
- W32481776 endingPage "30" @default.
- W32481776 startingPage "23" @default.
- W32481776 abstract "An important event in the pathogenesis of Alzheimer's disease (AD) is the deposition of the amyloid beta (Abeta)1-40 and 1-42 peptides in a fibrillar form, with Abeta42 typically having a greater propensity to undergo this conformational change. A major risk factor for late-onset AD is the inheritance of the apolipoprotein E (apoE) 4 allele [3,14,31]. We previously proposed that apoE may function as a pathological chaperone in the pathogenesis of AD (i.e. modulate the structure of Abeta, promoting or stabilizing a beta-sheet conformation), prior to the discovery of this linkage [7,40,41,42]. Data from apoE knockout / AbetaPP^(V717F) mice, has shown that the presence of apoE is necessary for cerebral amyloid formation [1,2], consistent with our hypothesis. However, in betaPP^(V717F) mice expressing human apoE3 or E4 early Abeta deposition at 9 months is suppressed, but by 15 months both human apoE expressing mice had significant fibrillar Abeta deposits with the apoE4 expressing mice having a 10 fold greater amyloid burden [8,9]. This and other data has suggested that apoE, in addition to having a facilitating role in fibril formation, may also influence clearance of Abeta peptides. In order to address if apoE affects the clearance of Abeta peptides across the blood-brain barrier (BBB) and whether there are differences in the clearance of Abeta40 versus Abeta42, we performed stereotactic, intra-ventricular micro-injections of Abeta40, Abeta42 or control peptides in wild-type, apoE knock-out (KO) or human apoE3 or apoE4 expressing transgenic mice. We found that consistent with other studies [5], Abeta40 is rapidly cleared from the brain across the BBB; however, Abeta42 is cleared much less effectively. This clearance of exogenous Abeta peptides across the BBB does not appear to be affected by apoE expression. This data suggests that Abeta42 production may favor amyloid deposition due to a reduced clearance across the BBB, compared to Abeta40. In addition, our experiments support a role of apoE as a pathological chaperone, and do not suggest an isotype specific role of apoE in exogenous Abeta peptide clearance from the CSF across the BBB." @default.
- W32481776 created "2016-06-24" @default.
- W32481776 creator A5025467257 @default.
- W32481776 creator A5035899769 @default.
- W32481776 creator A5060656369 @default.
- W32481776 creator A5072446565 @default.
- W32481776 creator A5088998527 @default.
- W32481776 date "2001-03-05" @default.
- W32481776 modified "2023-10-11" @default.
- W32481776 title "Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice" @default.
- W32481776 cites W1522048223 @default.
- W32481776 cites W1555517932 @default.
- W32481776 cites W1629602451 @default.
- W32481776 cites W1965496447 @default.
- W32481776 cites W1970610359 @default.
- W32481776 cites W1975849504 @default.
- W32481776 cites W1976721815 @default.
- W32481776 cites W1981554609 @default.
- W32481776 cites W1986651793 @default.
- W32481776 cites W1990702695 @default.
- W32481776 cites W1993356262 @default.
- W32481776 cites W1996791687 @default.
- W32481776 cites W1997913988 @default.
- W32481776 cites W1998208719 @default.
- W32481776 cites W2005413578 @default.
- W32481776 cites W2006014092 @default.
- W32481776 cites W2006409771 @default.
- W32481776 cites W2012293927 @default.
- W32481776 cites W2013833879 @default.
- W32481776 cites W2020945366 @default.
- W32481776 cites W2021181758 @default.
- W32481776 cites W2021333248 @default.
- W32481776 cites W2032920422 @default.
- W32481776 cites W2036362108 @default.
- W32481776 cites W2043656292 @default.
- W32481776 cites W2046847750 @default.
- W32481776 cites W2048509804 @default.
- W32481776 cites W2052557507 @default.
- W32481776 cites W2054115708 @default.
- W32481776 cites W2065410730 @default.
- W32481776 cites W2067811915 @default.
- W32481776 cites W2070897104 @default.
- W32481776 cites W2082504479 @default.
- W32481776 cites W2090710011 @default.
- W32481776 cites W2097608504 @default.
- W32481776 cites W2118569739 @default.
- W32481776 cites W2119556701 @default.
- W32481776 cites W2131068139 @default.
- W32481776 cites W2131975162 @default.
- W32481776 cites W2138955227 @default.
- W32481776 cites W2139304769 @default.
- W32481776 cites W2158965128 @default.
- W32481776 cites W2336965499 @default.
- W32481776 doi "https://doi.org/10.3233/jad-2001-3105" @default.
- W32481776 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12214069" @default.
- W32481776 hasPublicationYear "2001" @default.
- W32481776 type Work @default.
- W32481776 sameAs 32481776 @default.
- W32481776 citedByCount "79" @default.
- W32481776 countsByYear W324817762012 @default.
- W32481776 countsByYear W324817762013 @default.
- W32481776 countsByYear W324817762014 @default.
- W32481776 countsByYear W324817762015 @default.
- W32481776 countsByYear W324817762016 @default.
- W32481776 countsByYear W324817762018 @default.
- W32481776 countsByYear W324817762019 @default.
- W32481776 countsByYear W324817762020 @default.
- W32481776 countsByYear W324817762021 @default.
- W32481776 countsByYear W324817762022 @default.
- W32481776 crossrefType "journal-article" @default.
- W32481776 hasAuthorship W32481776A5025467257 @default.
- W32481776 hasAuthorship W32481776A5035899769 @default.
- W32481776 hasAuthorship W32481776A5060656369 @default.
- W32481776 hasAuthorship W32481776A5072446565 @default.
- W32481776 hasAuthorship W32481776A5088998527 @default.
- W32481776 hasConcept C102230213 @default.
- W32481776 hasConcept C104317684 @default.
- W32481776 hasConcept C126322002 @default.
- W32481776 hasConcept C134018914 @default.
- W32481776 hasConcept C141035611 @default.
- W32481776 hasConcept C142724271 @default.
- W32481776 hasConcept C170493617 @default.
- W32481776 hasConcept C182704531 @default.
- W32481776 hasConcept C185592680 @default.
- W32481776 hasConcept C2777633098 @default.
- W32481776 hasConcept C2777790613 @default.
- W32481776 hasConcept C2778163477 @default.
- W32481776 hasConcept C2778402981 @default.
- W32481776 hasConcept C2779134260 @default.
- W32481776 hasConcept C2779483572 @default.
- W32481776 hasConcept C2780942790 @default.
- W32481776 hasConcept C502032728 @default.
- W32481776 hasConcept C529278444 @default.
- W32481776 hasConcept C55493867 @default.
- W32481776 hasConcept C57089818 @default.
- W32481776 hasConcept C62746215 @default.
- W32481776 hasConcept C71924100 @default.
- W32481776 hasConceptScore W32481776C102230213 @default.